Delivery Order SPE2DB20D7061-SPE2DB25FSPU8
Award Date 9/17/25
Potential Completion Date 10/8/25
Potential Value $35K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $14,651.28 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gamunex-C 10 gram/100 mL vials (100 mL quantity). This is a firm fixed-price, non-set-aside contract with a completion date of October 8, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gamunex-C 5 gram/50 milliliter vials valued at $3,644.04 with a completion date of October 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with firm fixed pricing. This is a non-set-aside delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is executing this...
- The Defense Logistics Agency awarded a $23,272.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C (40 gram/400 ml vial), with an ultimate completion date of August 13, 2025. This is an unset-aside, competitively awarded contract that will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child order under a larger contract vehicle, this delivery order represents a single transaction within AmerisourceBergen's extensive pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,981.60 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400 milliliter immunoglobulin vial. The contract, issued on August 6, 2025, carries a firm fixed price and is scheduled for completion by August 27, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $7,080.84 delivery order contract to AmerisourceBergen Drug Corp for GAMUNEX-C (Immune Globulin Intravenous [Human]), a specialized pharmaceutical product supplied in 20 gram/200 milliliter vials. This firm fixed-price, non-set-aside contract is scheduled for completion by August 15, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine replenishment order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $11,801.40 with a firm fixed price. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $7,325.64 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 10 gram/100 mL immunoglobulin vial product, with an ultimate completion date of August 21, 2025. This competitive award, issued on July 31, 2025, utilizes a firm fixed price contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $28,323.36 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 20 gram/200 mL vials on July 22, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, represents a competitive award with no set-aside designation. The contractor will perform from its corporate headquarters location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,926.40 to AmerisourceBergen Drug Corp for the supply of Gamunex-C, a 40 gram/400 mL immunoglobulin product, with an ultimate completion date of June 17, 2025. The award, issued May 27, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, the...